Retinal Surgery Devices Market Propelled by Higher Patient Expenditure

Retinal surgery devices are a wide variety of devices used in surgical processes on the retina. The market for retinal surgery devices is growing at a rapid pace all over the world, thanks to the growth of the global geriatric population and significant technological advances in the devices. Due to the delicate nature of the retina, the latter is of particular importance to the overall demand for retinal surgery devices, since sophistication in devices helps lower the chances of mishaps during surgery.

Obtain the Future Market Trends of Retinal Surgery Devices at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4152

The report on the global retinal surgery devices market is a comprehensive document detailing the segmentation of the market, the factors determining the growth trajectory of the market, and describing in detail the competitive landscape of the market. The report employs reliable analytical tools such as market attractiveness analysis and value chain analysis to explain the market’s feasibility for investment, and the Porter’s five forces analysis to describe the dynamics between various aspects of the market.

Overview of the global retinal surgery devices market

The market for retinal surgery devices is growing on account of growing demand for ocular surgeries from the rising geriatric demographic. Owing to improving healthcare facilities and standards of living, the geriatric demographic is on the rise, particularly in developed countries. However, natural degeneration of the eye due to aging makes this demographic more prone to retinal disorders, leading to demand for retinal surgeries.

The aging populace is also more prone to chronic diseases such as diabetes, which leads to diabetic retinopathy in an overwhelming majority of diabetic patients. Surgeries to counteract the various effects of diabetic retinopathy are leading to an increased demand for retinal surgery devices. The application segment of retinal detachment is also rising in incidence around the world. The geriatric population is also a factor in the growth of this segment, since complications in cataract surgeries, which the geriatric demographic is more likely to need, can lead to retinal detachment.  The demand for retinal surgery devices in retinal detachment surgeries is expected to grow at the highest CAGR of all applications of retinal surgery devices during the forecast period.

Vitrectomy packs led demand for retinal surgery devices, accounting for the largest share of the market by product type in 2013. The reduced duration of retinal surgeries and recuperation thereafter are the main causes driving demand for vitrectomy packs.

North America led the geographical segmentation of the global market for retinal surgery devices, thanks largely to the highly developed healthcare infrastructure in countries such as the U.S. and Canada. Technological innovation in retinal surgery devices is also at the cutting edge in North America, which has helped increase the reliability of the devices. However, Asia Pacific stands to grow at the fastest CAGR during the forecast period.

Companies profiled in the research report

The report profiles the major players operating in the market, on the parameters of their financial profile, business operations, product catalog, and recent developments in the industry.

Read the Current Market Forecast of Retinal Surgery Devices at: http://www.transparencymarketresearch.com/retinal-surgery-devices-market.html

These include giants in the fields of optics and medical companies such as Carl Zeiss Meditec AG, Lumenis, Optos plc, Bausch and Lomb Inc., Alcon, Inc., and Leica Microsystems GmbH.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Respiratory Disease Testing Market to Gain Dominant Share in North America

The respiratory system plays a key role in the delivery of oxygen to the body and also removes carbon dioxide waste from the body. In addition, the system also eliminates toxic waste, stabilizes blood-alkaline balance (pH), and regulates temperature. Respiratory diseases inhibit this normal functioning of the respiratory system and may occur as a result of causes such as the inhalation of dangerous agents, smoking, and unhealthy lifestyles. A number of genetic factors, infections, and other factors impacting the development of the lungs, either indirectly or directly may also cause respiratory ailments.

Obtain the Forthcoming Market Trends of Respiratory Disease Testing at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1288

As per the report, the rising aging population raises the utilization of respiratory disease testing products, thus having a positive impact on the growth of the market. In addition, the increasing occurrence of respiratory diseases such as pneumonia, chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis also propels the growth of the market for respiratory disease testing. Furthermore, the rising technological developments will also have a positive impact on the development of this market. On the other hand, the report states that the decreasing adoption of advanced spirometers and digital radiography systems is a key factor impeding the growth of the market.

In terms of test, the respiratory disease testing market is segmented into spirometry tests, imaging tests, blood gas tests, peak flow tests, lung volume tests, and other tests. Amongst these, the segment of imaging tests led the market in 2013. The reason for the dominance of this segment is the increasing demand for imaging tests such as X-rays, etc. Additionally, imaging tests have also emerged as the first-line diagnostic tests for a number of respiratory diseases.

By end use, the respiratory disease testing market is segmented into physician offices, clinical laboratories, and hospitals. Amongst these, hospitals constituted the largest share in the market for respiratory disease testing in 2013. The reason for the dominance of this segment is the wide-ranging use of respiratory diagnostic instruments, particularly X-ray machines, within this segment. Furthermore, doctors globally have shown a high preference for in-house diagnostic tests for patients rather than relying on outside laboratory tests, thus resulting in an increased dominance of hospitals globally.

On the basis of geography, the report segments the market into North America, Europe, Asia Pacific, and Rest of the World (RoW). Amongst these, North America constituted the largest share in the market in 2013. This is owing to the rising occurrence of respiratory diseases and the increasing demand for home healthcare services and devices here. On the other hand, the Asia Pacific respiratory disease testing market is predicted to rise at the swiftest growth rate in the coming years.

Read the Current Market Trends of Respiratory Disease Testing at: http://www.transparencymarketresearch.com/respiratory-disease-testing.html

As per the report, the chief players operating in the market are COSMED, CareFusion Corp., Carestream Health Inc., Futuremed America Inc., GE Healthcare, NIHON KOHDEN Corp., Perkin Elmer Inc., Philips Healthcare, SDI Diagnostics, Smiths Medical, and Siemens Healthcare, among others.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Middle East and Africa Defibrillators Market Expand Their Businesses With New Investments

A defibrillator device depolarizes a critical part of a heart muscle thereby helping in restoration of normal heart rhythm. If SCA victims receive cardiopulmonary resuscitation (CPR) and defibrillation within 5 to 12 minutes of cardiac arrest, many lives can be saved. Cardiac arrest, arrhythmia, fibrillation, public access defibrillation, Cardio Pulmonary Resuscitation, emergency medical services, monitor/defibrillator, Lifepak, HeartStart, ZollThis report analyzes the Middle East and Africa defibrillators market for the period from 2012 to 2020. The report provides an in-depth, comprehensive analysis of the Middle East and Africa market from three perspectives: type of products, different end-users, and major geographies. Increasing public awareness, advancing technology and growing cardiovascular incidences are boosting the market growth for these devices in the region.

Obtain Upcoming Forecast of Middle East and Africa Defibrillators Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4459

According to the report, the MEA defibrillators market is primarily driven by the growing population of patients with heart issues, particularly the elderly. The MEA defibrillators market pertains to the occurrence of a sudden cardiac arrest, in which scenario a defibrillator is used. A defibrillator functions by transmitting an electric shock across its surfaces. The shock of anywhere between 40 Joules and 400 Joules is given to the heart, which interrupts cardiac arrhythmia and reinitiates the heartbeat.Therefore, the report suggests that the growing number of instances of sudden cardiac arrest in MEA are boosting the MEA defibrillators market.

The MEA defibrillators market is still hampered by the lack of a substantial consumer base that speaks English. With the majority of the MEA region housing a non-English-speaking population, the international players in the global defibrillators market have a tough time entering the Middle East and Africa defibrillators market. This language barrier is currently being mitigated through the use of voice assistance in local languages, CPR guidance, and other inbuilt features. Due to the use of these modern instruments, the MEA defibrillators market is expected to maintain its growth trajectory for the time being.

According to the report, the 2013 MEA defibrillators market was led by advanced life support in the categorization by product type. However, the segment of automated external defibrillators is expected to show the fastest growth rate within the report’s forecast period. The intention of using AEDs by the first responder and the increasing incidence of cases where life support and defibrillators are needed is boosting the AED segment.

The segment of AEDs is expected to grow even faster due to the adoption of AEDs by the UAE Public Safety Department in first aid installations in government offices, zoos, malls, and other public places.The key players in the MEA defibrillators market are Welch Allyn, Inc., Schiller AG, Nihon Kohden Corporation, HeartSine Technologies, Inc., Zoll Medical Corporation, Physio-Control, Inc., and Philips Healthcare.

Read the Current Market Trends of Defibrillators in Middle East and Africa region at: http://www.transparencymarketresearch.com/middle-east-africa-defibrillators-market.html

One of the key issues for the MEA defibrillators market is the overall lack of awareness about CPR procedures and proper use of defibrillators. Due to this, manufacturers in the MEA defibrillators market tend to avoid using a personal distribution network, and instead appoint authorized representatives that eventually become the company’s face to stakeholders and involved personnel, including regulatory bodies and physicians.

TMR CONTACT:

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Auto-Injectors Market is driven by Increasing Incidence of Anaphylaxis

Auto-injectors are mostly spring-loaded syringes used for injecting oneself with a preloaded, single dose of a drug. These injectors are easy to use and are generally utilized in the case of multiple sclerosis, anaphylaxis, or rheumatoid arthritis. The growing prevalence of anaphylaxis and allergies from food have fueled the demand for auto-injectors globally. Apart from this, the implementation of favorable reimbursement policies by various governments across the world is also propelling this market significantly.

Obtain the Upcoming Market Analysis of Auto-Injectors at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4199

The research report presents an in-depth analysis of the global market for auto-injectors. It studies the market on four fronts: The type of product, manufacturing design, application, and the region. Based on the type of product, the market has been categorized into fillable (reusable) auto-injectors and prefilled (disposable) auto-injectors. The prefilled auto-injectors segment enjoys a higher demand than the fillable auto-injectors segment on account of the ease of usage provided by prefilled auto-injectors.

By manufacturing design, the market has been classified into standardized auto-injectors and customized auto-injectors. The standardized auto-injectors segment dominated the overall market in 2013. However, analysts anticipate the customized auto-injectors segment to record the fastest growth during the forecast period, states the report.

Application-wise, the market has been grouped into rheumatoid arthritis, multiple sclerosis, anaphylaxis, and other applications. In 2013, the demand for auto-injectors was the highest from the anaphylaxis segment.

Regionally, the research report has segmented the worldwide market for auto-injectors into North America, Asia Pacific, Europe, and the Rest of the World. North America led the global market in 2013 with a share of 70%. The increased prevalence of anaphylaxis and the rise in the disposable income of individuals, enabling them to afford expensive treatments, have fueled the demand for auto-injectors in this region significantly. The presence of a favorable reimbursement environment has also boosted this regional market in the recent past.

Asia Pacific, however, is projected to emerge as the most promising regional market for auto-injectors over the forecast period. The rising incidence of multiple sclerosis and anaphylaxis in Australia and New Zealand, together with favorable reimbursement options in New Zealand, is likely to propel this regional market considerably during the forecast period. The growing awareness regarding novel treatment methods and increasing disposable income of people are also expected to drive the Asia Pacific auto-injectors market in the coming years, notes the research study.

Read the Current Market Trends of Auto-Injectors at: http://www.transparencymarketresearch.com/global-auto-injectors-market.html

Ypsomed Holding AG, Unilife Corp., Scandinavian Health Ltd., Sanofi, Novartis International AG, Mylan Inc., Biogen Idec, Becton, Dickinson & Co., and Antares Pharma Inc. are the major international players in the global auto-injectors market profiled in this market report.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Hemostasis and Tissue Sealing Agents Market is Majorly Driven by the Introduction of New Hemostat Products

Hemostasis and tissue sealing agents play a vital role in simplifying wound sealing procedures during surgeries. Primarily, the global hemostasis and tissue sealing agents market is driven by the introduction of new products. For example, in May 2014, the Sylys Surgical Sealant was introduced by Cohera Medical, Inc.; it can be used in gastrointestinal surgery. In January 2014, Baxter received the U.S. FDA approval for the TISSEEL fibrin sealant that is used for various surgeries. The constant introduction of new products and the increasing adoption of technological innovations are expected to propel the global hemostasis and tissue sealing agents market in the years to come.

Obtain the Future Market Forecast of Hemostasis and Tissue Sealing Agents at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4018

The increasing number of vascular, cardiovascular, pulmonary, and gastrointestinal surgeries has also increased the demand for hemostasis and tissue sealing agents. Factors such as the risk of complications of hemostasis and tissue sealing agents and strict regulatory requirements are expected to hamper the growth of the global hemostasis and tissue sealing agents market in the near future. However, the increasing investment in hemostasis and tissue sealing agents for developing agents is expected to benefit the global market in the near future.

Leading players are concentrating on introducing new innovative products in the global market. Some of the prominent companies operating in the global hemostasis and tissue sealing agents market are CryoLife, Inc., Advance Medical Solution Group plc, Pfizer, Inc., Johnson and Johnson, Baxter, and Integra LifeSciences Corporation.

The global hemostasis and tissue sealing agents market is segmented on the basis of product type and geography. Based on geography, the global market for hemostasis and tissue sealing agents is divided into North America, Asia Pacific, Europe, and Rest of the World. In 2013, North America dominated the global hemostasis and tissue sealing agents market owing to the rising number of pulmonary and cardiovascular surgeries. The Europe hemostasis and tissue sealing agents market is expected to expand at a 7.0% CAGR from 2014 to 2020 due to the introduction of products such as HEMOPATCH, TISEEL, and FLOSEAL.+

Read the Current Market Trends of Hemostasis and Tissue Sealing Agents at: http://www.transparencymarketresearch.com/hemostasis-tissue-sealing-agents-market.html

Based on product type, the global hemostasis and tissue sealing agents market is segmented into topical hemostats and adhesive and tissue sealing agents. The adhesive and tissue sealing agents segment is predicted emerge as the dominant contributor in the global market throughout the forecast period. Improved research and development activities towards drug discovery are expected to propel the adhesive and tissue sealing segment.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Acute Care Needleless Connectors Market Gains from Increasing Needlestick Injuries

Needleless connectors are utilized to connect catheters to syringes or IV systems. The increasing incidence of injuries from needlesticks to healthcare professionals and patients has augmented the prevalence of blood-borne diseases. As needleless connectors allow the easy administration of medicines as well as convenient withdrawal of blood intravenously, the demand for acute care needleless connectors has been rising significantly across the world since the last few years.

Future Analysis of Acute Care Needleless Connectors Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4230

According to the report, the global market for acute care needleless connectors market has experienced a sturdy rise in the recent times. The rising prevalence of diabetes, chronic pain, and cancer has propelled the demand for acute care needleless connectors globally.

In this research report, the global market for acute care needleless connectors has been studied on the basis of the type of design, mechanism, dwell time, and the region. Based on the type of design, the market has been segmented into simple connectors and complex connectors. The complex connectors segment led the overall market in 2013 with a majority share. However, the simple connectors segment is likely to register a faster growth rate over the forecast period.

Based on the mechanism, the worldwide acute care needleless connectors market has been categorized into the neutral fluid displacement segment, the negative fluid displacement segment, and the positive fluid displacement segment. In 2013, the positive fluid displacement segment acquired the leading position in the overall market with a share of approximately 34%. However, the neutral fluid displacement segment is estimated to register the highest growth at a CAGR of 11.0% during the forecast period, notes the market report.

By dwell time, the market has been grouped into seven days connectors and the other than seven days connectors. Over the forecast period, the other than seven days connectors segment is likely to register a higher growth rate than the seven days connectors.

On the regional basis, the global acute care needleless connectors market has been classified into Asia Pacific, Europe, North America, and the Rest of the World. North America emerged as the leading regional market for acute care needleless connectors in 2013.

The high awareness regarding these connectors among healthcare practitioners, infrastructural advancement in the healthcare industry, and the rapid rise in the geriatric population have driven the North America acute care needleless connectors market significantly over the last few years. However, Asia Pacific is projected to record the fastest growth in the overall market during the forecast period due to rising incidence of chronic diseases, states the research report.

Read the Current Market Trends of Acute Care Needleless Connectors at: http://www.transparencymarketresearch.com/acute-care-needleless-connectors-market.html

B. Braun Melsungen AG, Vygon SA, RyMed Technologies LLC, Nexus Medical LLC, ICU Medical Inc., CareFusion Corp., Becton Dickinson and Co., and Baxter International Inc. are the key international producers of acute care needleless connectors mentioned in this market study.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Latin America Minimally Invasive Surgery Market Driven by Increasing Government Support

According to the report, the Latin America minimally invasive surgery market is expected to exhibit a robust 10.8% CAGR from 2014 to 2020. The market was valued at US$925 mn in 2013 and is expected to more than double over the forecast period, reaching a value of more than US$1.9 bn by 2020.

Download the Upcoming Trends of Latin America Minimally Invasive Surgery Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3842

Minimally invasive surgeries are surgical procedures performed by making as few incisions on the patient’s body as possible. The reduction in blood loss and the increased ease and decreased duration of post-surgical care are the major benefits minimally invasive surgeries hold over conventional surgeries. Minimally invasive surgeries are thus more convenient for the patients, both during the procedure and after. These are crucial factors in the growth of the global minimally invasive surgery market.

Latin America is an important emerging region and contains many dynamic economies such as Brazil and Mexico. The steady economic growth of countries in the region has allowed governments to financially support large-scale adoption of minimally invasive surgeries. The higher cost of minimally invasive surgeries in comparison to conventional surgeries is the major restraint on the market at present. Additionally, making minimally invasive surgeries the norm rather than the outlier will require steady support from governments in Latin America.

However, the increasing GDP of the region has resulted in a growth in the disposable income of consumers, which will drive the Latin America minimally invasive surgery market in the coming years. The expected growth of the geriatric population in Latin America, as healthcare services become affordable and effective, will also drive the minimally invasive surgery market.

By product type, the Latin America minimally invasive surgery market was dominated by the surgical devices segment in 2013. Monitoring and visualization devices are crucial in minimally invasive surgeries in order to understand the structure of the internal organs being operated upon. It was the second largest product segment of the Latin America minimally invasive surgery market for 2013.

By type of surgery, the market for minimally invasive surgery in Latin America is divided into cardiac, thoracic, cosmetic, breast, bariatric, orthopedic, urological, gastrointestinal, and other surgeries. Of these, cosmetic surgeries are expected to exhibit the fastest rise in demand over the forecast period. The increasing urbanization and the consequent acceptance of Western values in Latin America are responsible for the increasing desire of consumers to retain a younger appearance. Orthopedic surgeries are also expected to exhibit a steady growth in demand due to the increasing prevalence of orthopedic conditions.

Regionally, Brazil and Mexico were the largest national segments of the Latin America minimally invasive surgery market, accounting for more than half the revenue of the market in 2013. Mexico is likely to remain the major hub in the Latin America minimally invasive surgery market in the coming years, due to the relatively easy access to advanced technology and the increasing purchasing power of consumers.

Read the Current Market Trends of Minimally Invasive Surgery in Latin America at: http://www.transparencymarketresearch.com/latin-america-minimally-invasive-surgery-market.html

Major companies examined in the report include GE Healthcare, Teleflex, Medtronic, Inc., Siemens Healthcare, and Stryker Corporation.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Vitreous Tamponades to Witness High Demand due to Increasing Incidence of Diabetic Retinopathy

Vitreous humor of the human eye is a vital component that acts as nutrition and refractive medium. The vitreous humor is initially a highly viscous gel like substance made up of collagen fibers and water. In case of trauma or upon aging, the vitreous humor disintegrates and in the process ends up tearing or detachment of highly fragile retina. Thus, these retinal detachment and vitreoretinal disorders often require an ophthalmic surgical procedure known as vitrectomy. Vitrectomy procedure involves surgical removal of the vitreous humor that is replaced with synthetic substitute known as vitreous tamponade. These vitreous tamponades act as a retinal reattachment medium thereby aiding the healing process.

Obtain the Future Market Trends of Vitreous Tamponades at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4233

Based on the important information provided in the report regarding the challenges that new entrants face, the strategies used by leading companies in the vitreous tamponades market, and also the present and future trends, an interested individual or enterprise can effectively make smart decisions regarding investment in the market.

Vitreous tamponades are used in vitrectomy procedures conducted in the human eye. These procedures assist in healing or reattachment of the retina and are also used to provide a replacement to a clouded vitreous humor. The vitreous humor of the eye acts as a refractive medium and provides nutrition to the eye. After a trauma or due to the natural process of ageing, the vitreous humor, which is a highly viscous gel-like substance made from collagen and water, starts tearing or getting detached from the fragile retina. To repair this retinal detachment and also for any other vitreoretinal disorders, vitrectomy is required. Vitrectomy involves the removal of the vitreous humor and replacing it with a synthetic substitute. This synthetic substitute is called a vitreous tamponade. Currently, the most commonly used substitutes are: silicone oil, perfluorocarbon liquids, and intraocular gases.

The global vitreous tamponade market is expected to expand due to the rising incidence of retinal detachment and growth of the geriatric population. The growing cases of diabetic retinopathy, macular pucker, and similar other retinal disorders are also driving the global vitreous tamponade market. Vitreous substitutes are biocompatible and transparent, which allow them to replace natural vitreous humor successfully.

The global vitreous tamponade market is segmented on the basis of type and geography. On the basis of type, the market is segmented into gaseous tamponades and liquid tamponades. Liquid tamponades are further classified into silicone oil and perfluorocarbons. Although the liquid tamponades market was the leading segment in 2013, accounting for 49% of the global market, the gaseous tamponades segment is expected to grow at a faster rate due to their ease of use and lower costs. The most extensively used gaseous tamponades in vitreoretinal surgeries are C2F8, SF6, and C3F8, as these gases are expansive and allow the eyeball and the retina to gradually adjust to the volume of the eye, enabling better healing.

Read the Current Market Analysis of Vitreous Tamponades at: http://www.transparencymarketresearch.com/vitreous-tamponades-market.html

Some of the key manufacturers of vitreous tamponades profiled in the report are: Valeant Pharmaceuticals International, Inc. (parent of Bausch + Lomb), Alcon, Inc., Carl Zeiss Meditec AG, Fluoron GmbH, Dutch Ophthalmic Research Center B.V., AL.CHI.MI.A Srl, and Croma Pharma AG.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Pressure Relief Devices Market - Business Alliances to Open New Growth Opportunities for Players

Strong customer relations to attain long-term business goals is a key growth model that companies in this market are adopting. A case in point is ArjoHuntleigh, the company is focused on developing strong relations with customers by means of providing customized services.

Future Market Projections for Pressure Relief Devices at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1743

Investment in emerging markets to increase market share is also what key companies in this market are looking upon. For example, Covidien plc has substantially invested in the emerging markets of APAC to leverage the opportunities available in this region.

Limited Mobility of Geriatrics Pose a High Risk of Developing Pressure Ulcers

“An increasing number of obese population worldwide is boosting the growth of the global market for pressure relief devices,” points out a TMR analyst. The prevalence of obesity has doubled between 1980 and 2014, according to the World Health Organization. The increasing obese population is displaying an increased demand for pressure relief devices such as mattress overlays and specialty beds to prevent pressure ulcers.

The increasing geriatric population is also fuelling demand for pressure relief devices. This is because elderly people have high chances of developing pressure ulcers due to reduced blood flow, damaged nerves, and limited mobility.

Unfavorable Reimbursement Policies Adversely Affect Uptake of Pressure Relief Devices

High cost of pressure relief devices and unfavorable reimbursement policies for the same are impeding this market’s growth. Changes in reimbursement policies for pressure relief devices in recent years have been detrimental to the market’s growth. This is because treatment of pressure ulcers is an expensive affair, for which reimbursement is essential for the patient. For example, the price range of an air fluidized therapy bed is from US$15,000 to US$25,000. Moreover, adoption of reimbursement restrictions for pressure ulcers on the part of private insurers, especially in developing nations such as China, India, Brazil, and Mexico is restraining the market’s growth.

The global market for pressure relief devices is expected to reach a valuation of US$2.8 bn by 2020. On the basis of device type, low-tech devices led with 86.9% of the overall market in 2013. This segment is expected to display a higher growth rate over its counterpart hi-tech device segment in the coming years. This growth is mainly owing to the advantages of low-tech devices pertaining to prevention of ulcer, easy operability, and cost effectiveness.

Read the Current Market Trends of Pressure Relief Devices at: http://www.transparencymarketresearch.com/pressure-relief-devices.html

In 2013, North America stood as the leading market for pressure relief devices. However, Asia Pacific is anticipated to display the fastest growth rate in the coming years due to an increasing geriatric population base in this region.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Remote Patient Monitoring Devices Market to Expand Owing to Growing Prevalence of Chronic Diseases

Remote patient monitoring is one of the latest innovations in the healthcare industry. In line towards an overall shift in healthcare dispensation towards home care and preventive measures, remote patient monitoring devices allow patients to keep a check on their own conditions, eliminating the need for repeated visits to the physician’s office. The precision of remote patient monitoring devices also allows for a trustworthy diagnosis, allowing for a more customized and effective treatment or post-treatment recuperative plan.

Download the Future Perspective of Remote Patient Monitoring Devices Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=401

The report on the global remote patient monitoring devices market analyzes the global market on the parameters of product type, end users, and geography. Segments according to each criterion are examined for their historical growth; growth projections over the forecast period are presented for each segment. The growth drivers and restraints of the market are also analyzed for their potential impact on the market in the forecast period, and the market’s value chain is analyzed. The remote patient monitoring devices market’s competitive landscape is also analyzed in detail, with the influence of major players examined through the SWOT and Porter’s five forces analyses.

Overview of the global remote patient monitoring devices

Remote patient monitoring devices are gaining demand due to various factors. The prime growth drivers for the market are the growing prevalence of chronic diseases such as diabetes, arthritis, and osteoporosis around the world. It is more feasible for both patients and doctors to check upon the patient’s progression once in a while rather than with regular visits to the hospital or hospitalization. The rise in the geriatric demographic all over the world is adding to this factor, since this demographic is most commonly treated for these conditions.

Growing load on hospitals to admit patients, complemented by the preference of patient to receive treatment in their own households, is also helping the global remote patient monitoring devices market.

The major restraint on the market is the reluctance of patients to have their daily lives logged and tracked through the remote monitoring devices. However, growing usage of remote patient monitoring devices would help increase the trust consumers place in them, thus helping demand.

Among the products in the global remote patient monitoring devices market, heart monitors, breath monitors, physical activity monitors, hematology (blood) monitors, and multi-sign monitors are the major categories. Heart devices, particularly ECG devices, were the leading category in the market as of 2013, due to the high incidence of lifestyle-induced cardiac diseases in developed countries. The high prices of ECG and other heart monitors are also responsible for their high valuation.

Geographically, the market for remote patient monitoring devices is the largest in North America. This region exhibits a confluence of all the major drivers of the market, including a large geriatric population, availability of advanced monitoring devices and the financial ability of the population to use such devices, and high prevalence of lifestyle diseases such as hypertension, diabetes, and other cardiac diseases. Growing impact of these very factors is expected to make Asia Pacific the fastest growing market for remote patient monitoring devices in the forecast period.

Read the Current Market Trends of Remote Patient Monitoring Devices at: http://www.transparencymarketresearch.com/remote-patient-monitoring-devices-market.html

Companies profiled in the research report

The report includes detailed analysis of the business operations of major players in the remote patient monitoring devices market, such as Abbott Laboratories, Covidien plc, F. Hoffman-La Roche Ltd., Omron Healthcare Inc., AMD Global Telemedicine, and Honeywell HomMed LLC.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Contrast Media Injectors Market Grows Constantly due to Significant Increase in Diagnostic Procedures

With a highly consolidated landscape, the global contrast media injectors market is characterized by a high degree of competition between the top three players, namely, Medrad Inc., Bracco Imaging S.p.A, and Mallinckrodt Pharmaceuticals, finds Transparency Market Research (TMR) in a recent report. In 2013, these enterprises collectively held a share of more than 80% of the overall market. Their strong geographical presence and wide-ranging product portfolios have helped these companies in establishing themselves as the leading producers of contrast media injectors across the world.

Obtain the Forthcoming Market Trends of Contrast Media Injectors at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2406

TMR estimates the global market for contrast media injectors, which stood at US$630.1 mn in 2013, to reach an opportunity worth US$886.7 mn by 2020, expanding at a CAGR of 5.0% between 2014 and 2020. New entrants will need to adopt the strategy of product bundling (bundling of their injectors with popular imaging equipment or contrast media) in order to reach out to customers.

Increasing Need for Contrast Scanning to Stimulate Demand for Contrast Media Injectors

“With the growing prevalence of various life-threatening medical conditions, such as cardiac and neurological disorders, there has been a significant increase in diagnostic procedures performed across the world” states an analyst at TMR. According to the Organization for Economic Co-operation and Development (OECD), more than 30,000 scanners and approximately 17,000 MRI platforms were being utilized, globally, in 2013. Over the coming years, these numbers are likely to witness a substantial rise due to the increasing accessibility to these platforms.

Apart from this, the rising incidence of cancer, hemorrhage, complex fractures, cardiovascular disorders, and bone trauma are also projected to increase the need for contrast scanning to identify the tissues that differ in physical density, leading to a surge in the demand for contrast media injectors in the near future.

Currently, developed countries, such as the U.S., the U.K., and Germany provide a wider base for the application of technically advanced imaging platforms. However, in the coming years, emerging economies will present a rather lucrative market for participants due to the augmenting patient pool and the growing need for effective diagnosis.

Demand for Contrast Media Injectors to be Hampered by their High Cost

Although analysts predict the demand for contrast media injectors to rise significantly in the years to come, the high cost associated with them may create some hindrance in their growth trajectory. The cost of contrast media injectors is directly proportional to the level of technological sophistication. As high-end injectors are heavily priced, the availability low-end devices, especially in Asia Pacific, is likely to limit their adoption, resulting in the decline in the overall sale of contrast media injectors in the years to come.

Other than this, the growing concerns regarding adverse reactions, such as mild nausea, vomiting, and rashes, associated with the usage of contrast media or agents are also projected to negatively impact the application of contrast media injectors over the next few years.

North America to Remain Important Market for Contrast Media Injectors

North America has emerged as the key contributor to the revenue generated in this market and is expected to remain in the leading position over the forecast period. In 2013, the region accounted for a total revenue of US$218.3 mn. Asia Pacific, however, is likely to register the fastest growth in the demand for contrast media injectors at a CAGR of 6.50% between 2014 and 2020.

Read the Current Market Trends of Contrast Media Injectors at: http://www.transparencymarketresearch.com/contrast-media-injectors-market.html

Among applications, the neurology segment led the consumption of contrast media injectors in 2013. However, the cardiology segment is expected to exhibit a higher demand for these injectors that the neurology segment by 2020. CT contrast injectors will remain the most preferred injector across the world throughout the forecast period, states the report.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Capnography Equipment Market to Rise due to High Prevalence of Spiraling COPD

Driven primarily by the growing occurrence of respiratory diseases that demand effective treatment, the global capnography equipment market will reach a valuation of US$615.6 mn by 2020, says a latest report by Transparency Market Research. The report, which is titled, ‘Capnography Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,’ says that the market stood at US$187.2 mn in revenue in 2013. The projected CAGR of the global capnography equipment market is 18.7% between 2014 and 2020.

Obtain the Future Market Trends of Capnography Equipments at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1585

Capnographs are used to measure excreted CO2 levels into the bloodstream, and form an integral part of the essential monitoring tools used during intensive care or anesthesia.With capnographs having become increasingly sophisticated over the years, they have proven their efficacy and reliability. This has also caused the demand for capnographs to increase through the years. Another driver that will help the market register a healthy rate of growth is the introduction of various regulatory guidelines concerning sedation procedures. Yet, the market will be prevented from achieving an even higher rate of growth because of the availability of cheaper substitutes to capnographs, such as pulse oximeters. Nevertheless, the growth of the capnography equipment market in emerging countries in Latin America and Asia Pacific will offset the negative impact of substitutes on the global market.

The growing prevalence of COPD and asthma in emerging economies will create new growth opportunities for companies in the global capnography equipment market.This report segments the global capnography equipment market on the basis of products, end-users, and geography. By product type, the market is segmented into: capnographs and capnography disposables. The former is sub-segmented into mainstream capnographs, sidestream capnographs, and microstream capnographs. With a sizeable share of 50% in the global capnography equipment market by product type, the sidestream capnographs segment was the most dominant as of 2013. The projected rate of growth of the microstream capnographs segment is very strong (18% over the report’s forecast period), making this space attractive for investments. Microstream capnographs come with several advantages, the main ones being their use in non-intubated patients and neonatal patients.

Likewise, on the basis of geography, the report segments the global market into the following regional markets: North America, Asia Pacific, Europe, and Rest of the World (RoW). North America held 60% of the global capnography equipment market in 2013, making it the single-largest regional market. The fastest growth in the global capnography equipment market between 2014 and 2020, however, will be seen in Europe, says the report. The market for capnography equipment in Europe is primarily driven by the increasing cases of respiratory failure, conducive government standards and regulations, and sliding prices of capnographs sold in the region.

Read the Current Market Analysis of Capnography Equipments at: http://www.transparencymarketresearch.com/capnography-market.html

The report also features a comprehensive section on the competitive landscape of the global capnography equipment market. The leading players that have been discussed in the Company Profiles chapter include: Dragerwerk AG, Covidien, plc., Medtronic, Inc., Masimo Corporation, Nonin Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, Welch Allyn, Inc., and Smiths Medical.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Increasing Need to Prevent Sexually Transmitted Diseases Steers Rise of Contraceptives Market

Contraceptives are defined as drugs and devices that help in preventing pregnancy. These devices also prevent spreading of sexually transmitted infection. Various awareness initiatives taken by market players is the major factor propelling the growth of contraceptives market. Bayer HealthCare, a major player in the contraceptives market, in coalition with 11 NGOs, organizes the World Contraception Day every year on September 26 to spread awareness about contraceptive methods, enabling young people to take right decision about their reproductive health.

Future Analysis and Trends for Contraceptives Market is available at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=344

This report provides in-depth analysis of the global contraceptives drugs and devices market. The stakeholders for this report include companies involved in the research and development, manufacturing and commercialization of contraceptive drugs and devices, suppliers and new entrants who are planning to invest in this market. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition for different contraceptive drugs and devices in four major geographies.

The market overview section of this report analyzes market dynamics such as drivers, restraints and opportunities that influence the contraceptives market in the current and future scenario. Further, Porter’s five forces analysis and market attractiveness analysis have been included in market overview section in order to explain the intensity of competition in the market. Porter’s five forces analysis is also elucidated in the section to understand the attractiveness of the contraceptive market in terms of five different attributes that have an effect on the sustenance of the players in the contraceptives market. Competitive scenario among the market players is analyzed through a heat map of major market players in the competitive landscape section of the report. All these factors will help the market players to decide about the business strategies and plans to be incurred in future for strengthening their position in the global market.

Based on the product types, the global contraceptives market is segmented into two major segments, namely, contraceptive drugs and contraceptive devices. Contraceptive drugs are further categorized into three segments including contraceptive pills, contraceptive injectables and topical contraceptives. Contraceptives devices segment is also further classified into two segments, male contraceptive devices and female contraceptive devices. Male contraceptive devices segment includes male condoms while female contraceptive devices are further differentiated into female condoms, intrauterine devices (IUDs), contraceptive sponges, contraceptive vaginal rings, subdermal contraceptive implants, contraceptive diaphragms and non-surgical permanent contraceptive devices. IUDs market is further segmented into copper IUD and hormonal IUD. Market revenue in terms of USD million for the period 2012 to 2020 along with the compound annual growth rate (CAGR %) from 2014 to 2020 is analyzed for the various types of contraceptive drugs and devices, considering 2013 as the base year.

Geographically, the contraceptives market has been differentiated into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). This section of the report provides market estimation in terms of revenue (USD million) of contraceptives market in these four regions from 2012 to 2020. Market revenue for contraceptive drugs and devices is also provided for geographies along with CAGR % for period 2014 to 2020, considering 2013 as the base year.

Read the Present Market Status of Contraceptives at: http://www.transparencymarketresearch.com/contraceptives-market.html

This report also includes recommendations section that will assist new companies in establishing their presence and market players in expanding their market share in the contraceptives market. The report concludes with the company profile section which includes company overview, financial overview, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include Actavis, Inc., Bayers AG, Church & Dwight, Co., Inc., CooperSurgical, Inc., Mayer Laboratories, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd. and The Female Health Company. 

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

High Unmet Healthcare Needs in Under-developed Economies Open Growth Opportunities for Video Telemedicine Market

The global video telemedicine market is highly consolidated with top four players collectively holding close to 90% of the overall market in 2013, as per a new analysis by Transparency Market Research. These are Cisco Systems Inc., Polycom Inc., LifeSize, and Vidyo Inc. Among these, Cisco Systems Inc. was the clear leader in the same year thanks to its diversified product portfolio and extensive geographical presence.

Obtain the Future Market Forecast of Video Telemedicine at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=536

“Partnerships and collaborations are the key focus of top players in the global video telemedicine market in the bid to expand their geographical presence”, points out a TMR analyst. This is mainly to improve remote and rural patient care, security, and communication. An excellent example is AMD Global Telemedicine Inc. collaborated with Nexus Connected Healthcare in September 2012, the latter being a subsidiary of Nexus IS Inc., to augment the applications of telemedicine.

Technological innovation and integration of applications is another key growth model that leading players are adopting to enhance their portfolio and broaden their regional footprint in the process. This is expected to increase the scope of video telemedicine from early detection and diagnosis to therapeutics.

Innovation in product design is also what top players in the global video telemedicine market are adopting for revenue growth. For instance, Global Media Group LLC’s TotalExam HD is the one of the world’s first true HD examination cameras.

Introduction of Government Reforms Favors Remote Healthcare Services 

“The global video telemedicine market is primarily driven by the rapidly increasing aging population that needs remote health diagnosis and monitoring”, says a TMR analyst. Moreover, regular healthcare needs of this population are driving the demand for mobile health and video telemedicine. According to estimates from the World health Organization (WHO), the percentage of individuals above the age of 60 years would double from 11% in 2011 to 22% by 2050. This indicates a significant rise in the geriatric population base would propel the need for efficient healthcare services that can be rendered remotely.

Government reforms that are favorable for improving the quality of healthcare is also fuelling the growth of the global video telemedicine market, says a TMR analyst. Proliferation of communication technologies and electronic devices is also propelling the growth of the global video telemedicine market.

Lack of Infrastructural Capabilities in Developing Countries Hampers Market Growth

Resistance for adopting new technologies, predominantly in developing nations such as India, Brazil, China, and Argentina is challenging the market’s growth. This is because the majority of the individuals in these countries prefer visiting the healthcare practitioner in place of receiving medical care remotely. Lack of modern healthcare infrastructure in several countries, which can support the deployment of video telemedicine is also restraining the market’s growth. Video telemedicine requires a high-level of technological capacity for the transmission of data and images unambiguously across the recipient’s network.

The dearth of skilled personnel that can operate video telemedicine systems is also an impediment to the growth of this market. The use of video telemedicine also requires dedicated medical personnel at all times to respond to queries.

Read the Current Market Trends of Video Telemedicine at: http://www.transparencymarketresearch.com/v-telemedicine-market.html

The global video telemedicine market is expected to be worth US$1,624.4 mn by 2020. Video telemedicine based on asymmetric digital subscriber line (ADSL) communication technology contributed the highest revenue to the overall market in 2013. However, the 4G communication technology segment of the market will display the highest growth rate at a CAGR of more than 18% between 2014 and 2020. Gynecology stood as the leading application segment in 2013; however, neurology and psychiatry application segments are expected to display the highest growth rate during the forecast horizon, the report states.

Increasing Hospitalization due to High Prevalence of Chronic Diseases Boosts Growth of Urinary Catheter Market

Rise in geriatric population along with increasing number of patients with urinary disorders is expected to boost demand for urinary catheters. The report forecasts growth of the global urinary catheters market at a CAGR of 5.1% during the period from 2014 to 2020. The report describes the market landscape and points out the key growth drivers, restraints, latest trends, and future opportunities in the global urinary catheters market. Insightful data related to overall market revenue along with an analysis regarding market attractiveness has been included in the report to provide a broader picture of the global urinary catheters market.

Obtain the Future Market Analysis of Urinary Catheters at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3936

The report analyses the effect of Porter’s five forces on the global urinary catheters market and, through SWOT analysis, it forecasts the future trajectory of key market players in the coming years. On the basis of key geographical regions, comparative analysis of the overall market during the forecast period has been mentioned in the report.

Overview of Global Urinary Catheters Market

Conditions such as urinary incontinence, urinary retention, surgery on the prostate gland or genitals, and other medical conditions including multiple sclerosis, dementia, and spinal cord injury lead to the usage of urinary catheters. The report cites the rising number of such disorders to drive the growth of the global urinary catheters market.

The global geriatric population is also expected to increase demand for technologically advanced urinary catheters, thereby fuelling overall market growth during the period between 2014 and 2020. However, the report points out that the rising number of catheter-associated urinary tract infections (CAUTIs) across the globe will negatively affect the market. Growing patient pool in emerging economies, rising awareness level among the same, and increased government support has been termed by the report as the key drivers to propel the market in the coming years.

Depending upon product type, the report segments the global urinary catheters market into intermittent (temporary) catheters, male external (condom) catheters, and Foley (indwelling) catheters. The report discusses the preference of healthcare specialists for intermittent catheters over other types due to the risk of urinary tract infections attached to other types of catheters.

The report studies the urinary catheters market in Asia, Europe, North America, Latin America, and Rest of the World. North America has been the leading regional segment of the global urinary catheters market, owing to high demand for urinary catheters from the U.S. and Canada. However, the report suggests that increasing geriatric population in Asia, especially in India, China, and Japan will drive the global urinary catheters market during the forecast period.

Read the Current Market Analysis of Urinary Catheters at: http://www.transparencymarketresearch.com/urinary-catheters-market.html

Companies mentioned in the research report:

The report profiles key players operating in the global urinary catheters market such as Boston Scientific Corporation, Cook Medical Inc., Covidien, Cure Medical, Hollister Incorporated, Teleflex Incorporated, Coloplast A/S, and B. Braun Melsungen AG. The report analyzes the market share held by each player. The financial overview, product portfolio, and business strategies of the players have been mentioned in the report. 

Standardization of Rental Regulations a Must for Medical Equipment Rental Market

According to the research report, in 2013, the global market for medical equipment rental was valued at US$33.4 bn and is estimated to reach a value of US$49.1 bn by the end of 2020. The market is projected to register a 5.80% CAGR between 2014 and 2020.

Obtain the Future Trends of Medical Equipment Rental Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2543

The rising pressure to reduce expenses in hospitals, the growing incidence of chronic diseases, increasing geriatric population, and safety against obsolescence of technologies are some of the major factors that are expected to boost the demand for medical equipment rental throughout the forecast period. Moreover, the expansion of the distribution network in developing countries is further expected to fuel the growth of the market. However, the poor pricing flexibility and absence of appropriate regulatory policies are projected to hamper the growth of the global medical equipment rental market in the near future.

The global medical equipment rental market has been classified on the basis of device category into surgical equipment, electronic/digital equipment, personal/home care equipment, durable medical equipment, and storage and transport. In 2013, the durable medical equipment segment held a 40% share of the global medical equipment rental market. This segment is projected to remain in its leading position in the forecast period, exhibiting a 5% CAGR between 2014 and 2020.

Furthermore, the global medical equipment rental market has been categorized on the basis of end use into medical equipment rental, personal/home care, and institutional medical equipment rental. In 2013, the chronic and geriatric patient sub-category of personal/home care held a 50% share of the overall personal/home care segment.

On the basis of geography, the global medical equipment rental market has been divided into Asia Pacific, Europe, North America, and Rest of the World. In 2013, Europe led the global market, accounting for a 30% share in the overall medical equipment rental market, followed by the North America medical equipment rental market. The North America market is estimated to surpass Europe in the next few years. On the other hand, the Asia Pacific market for medical equipment rental is anticipated to register the highest growth rate – a 6% CAGR between 2014 and 2020.

Furthermore, the research study covers the competitive landscape of the global medical equipment rental market, including detailed profiles of the major players operating in the market. As per the study, the global medical equipment rental market is extremely fragmented, owing to the dominance of a few large players such as Siemens Financial Services, Apria Healthcare Group, Stryker Corporation, and Hill-Rom Holdings, Inc.

Read the Current Analysis of Medical Equipment Rental Market at: http://www.transparencymarketresearch.com/medical-equipment-rental.html

Some of the other players in the market are Universal Hospital Services, Inc., Port Huron Hospital Medical Equipment, Hill-Rom Holdings, Centric Health Corporation, Westside Medical Supply, Woodley Equipment Company Ltd., US Med-Equip, Nunn’s Home Medical Equipment, and Walgreen Co.

Use of Newer Technologies to Aid Wound Healing Propels Demand for Negative Pressure Wound Therapy

The growing prevalence of chronic ailments such as cardiovascular diseases, diabetes, and peripheral vascular diseases has spurred the negative pressure wound therapy (NPWT) market. Patients who suffer from acute illnesses such as cancer and neurological disorders often have to stay in hospitals for a longer period of time, thereby leading to long-term bed occupancy. This in turn increases the rate of decubitus ulcers.

Obtain the Future Market Trends of Negative Pressure Wound Therapy at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1718

Continuously increasing geriatric population also increases the financial burden on healthcare authorities. As a result, patients nowadays prefer the compact, portable, and easy-to-use NPWT devices. The USP of NPWT devices is that they can be used conveniently at home, which is a key factor propelling the global negative pressure wound therapy market.

This report presents a detailed analytical overview of the NPWT market, with its key focus on analyzing the growth drivers, market restraints, potential threats, and opportunities. For a detailed market study, the global NPWT market has been classified on the basis of products and geography.

Based on product type, the market for NPWT is bifurcated into conventional NPWT devices and single use NPWT devices. The conventional NPWT devices segment encompasses canisters, pumps, dressing kits, and tubes. Of the key market segments, single use NPWT devices are forecast to expand at an incredible17.7% CAGR during 2014-2020.

The report is drafted comprehensively to provide insights on the NPWT market and help stakeholders determine their future course of action.

Overview of the global negative pressure wound therapy market

Since its advent in 1997 in the U.S., NPWT has evolved considerably. Advanced dressing features and functionalities have been introduced to enhance efficiency of the procedure and to make the process more user-friendly. The improved features and functionalities of NPWT has made the system more suitable for use in hospitals, healthcare and rehab centers, and home environments.

The report predicts that the global NPWT market, which stood at US$1.5 billion in 2013, will reach an estimated valuation of US$2.9 billion in 2020, developing at an impressive 10.2% CAGR between 2014 and 2020.

According to a recent report published by the American Diabetes Association, almost 30 million children and adults worldwide are affected by diabetes. 15% of the people suffering from this ailment experience foot ulcers at some point of their life. This often leads to infections, gangrene, and ulceration, which are complicated and expensive consequences of diabetes. Hence, the demand for NPWT is significantly augmented across the globe to ensure efficient treatment of such patients.

Read the Current Market status of Negative Pressure Wound Therapy at: http://www.transparencymarketresearch.com/negative-pressure-wound-therapy.html

Companies mentioned in the research report 

Some of the prominent vendors operating in the market identified in the report are Talley Group Limited, ArjoHuntleigh International AB, Medela AG, Mölnlycke Health Care AB, ConvaTec, Inc., Devon Medical, Inc., Kinetic Concepts, Inc., Smith & Nephew PLC, Genadyne Biotechnologies, Inc., and Prospera Technologies LLC.

Increasing Count of Hospitals in Developing Economies has Boosted Medical Specialty Bags Market

Medical specialty bags are utilized in preventing, assisting, and treating numerous types of disorders such as cancer, ostomy, ophthalmic, and ophthalmic diseases. They are also utilized for laparoscopic surgical procedures and urinary surgical procedures, among others. The demand for surgeries is on the rise owing to the increasing occurrence of chronic diseases and the growing count of accidents, thus fuelling the demand for medical specialty bags. Medical specialty bags are extensively used within healthcare institutions and hospitals.

Future Market Analysis of Medical Specialty Bags at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=632

As per the report, the increasing count of hospitals in developing economies has boosted the market for medical specialty bags. In addition, the swiftly increasing aging population is a key factor impacting the market positively. Furthermore, the supportive reimbursement policies have encouraged the adoption of expensive treatments amongst patients, driving the growth of the market. The flexibility in FDA approval norms in case of 510k exempted class I devices is also a chief factor augmenting the growth of the market for medical specialty bags. Additionally, the improvement of the healthcare sector in developing nations has raised the count of healthcare procedures, thus propelling the development of the market. The soaring count of chronic diseases globally has also resulted in the increased demand for medical specialty bags. On the other hand, the absence of awareness about diseases in some underdeveloped nations has lowered the count of healthcare procedures, thereby inhibiting the development of the market.

In terms of product, the report segments the market into bile collection bags, anesthesia breathing bags, blood bags, enema bags, enteral feeding bags, continuous ambulatory peritoneal dialysis (CAPD) bags, ostomy collection bags, urinary collection bags, resuscitation bags, intravenous fluid/infusion bags, and others including cadaver bags and ice bags. Ostomy collection bags are further segmented into multi-use ostomy bags and single-use ostomy bags. Ostomy collection bags led the market in 2013 due to the increasing occurrence of chronic diseases such as Ulcerative Colitis and Crohn’s disease, the increasing disposable incomes of consumers, and the rising count of customer awareness programs. On the other hand, by volume, intravenous fluid bags led the market owing to the rising usage of these bags in a number of healthcare procedures. The segment of blood bags is poised to be the most swiftly developing segment in the forecast horizon on the basis of both volume and size owing to the launch of PVC-free blood bags and the increasing occurrence of blood infusion emergencies globally.

By geography, the report segments the market into Europe, North America, Asia Pacific, and Rest of the World (RoW). Amongst these, North America led the market in 2013 owing to the increasing presence of reimbursement policies, the rising occurrence of diseases, the mounting adoption of innovative products, and the rise in obesity and related diseases within this region. Asia Pacific, on the other hand, is predicted to emerge as the most promising market in the forecast horizon owing to the robust economic development in nations such as Singapore, the Philippines, China, India, and Australia.

Read the Current Market Trends of Medical Specialty Bags at: http://www.transparencymarketresearch.com/medical-specialty-bags-market.html

The major players dominant in the market are Coloplast A/S, Hollister Incorporated, Baxter International, Inc., Medline Industries, Inc., Nolato AB, and Macopharma SA, among others.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Technological Breakthroughs to Augment Utility of Deep Brain Stimulation Devices

Since its inception about three decades ago, the fundamentals of software and hardware design for deep brain stimulation (DBS) have largely remained stagnant. However, improved understanding of disease progression pertaining to movement disorders combined with patient and clinician demands has led to the development of more advanced DBS technology. This will open growth avenues for deep brain stimulation and its allied realms, according to a research report by Transparency Market Research.

Perceive the Future Market Analysis of Deep Brain Stimulation Devices for Parkinson’s Disease at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1435

While new electrode design for deep brain stimulation devices has enabled multi-target stimulation sans side-effects, new user-friendly software enables computational modelling and individualized directed programming.

Q. What is the usability of DBS devices for Parkinson’s disease?

A. The use of deep brain stimulation for Parkinson’s disease involves treating several disabling neurological symptoms such as tremor, slowed movement, rigidity, stiffness, and walking problems. While drug therapy is most commonly used for the treatment of Parkinson’s disease in initial stages, surgical intervention using DBS devices are used to control the symptoms of the disease in advanced stages.

DBS devices are effective, clinically proven and have received legal approvals for the advanced treatment of mild to severe form of Parkinson’s disease. The endorsements for the usability of these devices will benefit the growth of the deep brain stimulation devices market.

Q. How have technological advances benefitted the growth of the DBS devices market?

A. Tremendously. In a recent industry development, GlaxoSmithKline and Verily have joined hands to establish Galvani Bioelectronics – a joint venture for the development miniature implantable devices to modify nerve signals and also to collect information about the body’s neural networks. These miniature devices are designed to communicate with a hand-held receiver and leverage analytics and to treat patients more precisely.

This technology has been announced as bioelectronics medicine that works on the target area, unlike drugs that affect the entire body.

Q.  What are the major factors propelling the growth of deep brain stimulation devices market?

A. The global deep brain stimulation devices market is driven by several factors. A rising geriatric population globally, an increasing incidence of Parkinson’s disease, and rising awareness about neurological movement disorders is fuelling the growth of this market. Moreover, favorable reimbursement policies are also contributing to the growing acceptance of these devices across the world.

Q. What are the factors holding back the growth of the deep brain stimulation devices market?

A. The risks associated with deep brain stimulation surgeries are the foremost factor holding back the market’s growth. Furthermore, the implementation of certain governmental policies such as the Affordable Care Act in the U.S. will hinder the growth of this market to some extent.

Interpret the Current Market Trends of Deep Brain Stimulation Devices for Parkinson's Disease at: http://www.transparencymarketresearch.com/deep-brain-stimulator-market.html

The high-cost factor of deep brain stimulation surgical procedure is also restraining the market’s growth. However, the growing burden of Parkinson’s disease on healthcare systems of developed countries has necessitated original equipment manufacturers (OEMs) to develop cost-effective devices for the treatment of Parkinson’s disease.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Emergence of Home-based Healthcare to Shape Utilization of Mobile Imaging Services

Mobile imaging services comprise a group of devices and technologies that allow diagnostic imaging to be conducted in non-hospital settings and the results sent to physicians. This is especially convenient in situations where the patient is suffering from disorders that restrain their movement, or the patient is in a remote area and can’t physically visit the hospital. The growing demand for home healthcare solutions is thus favorable for the mobile imaging services market. Hospitals themselves are also exhibiting increasing demand for mobile imaging services, as they present a cost-effective alternative over conventional fixed medical imaging equipment.

Obtain the Future Market Analysis of Mobile Imaging Services at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1560

According to Transparency Market Research, the global mobile imaging services market was valued at US$10.7 bn in 2013. Exhibiting a steady 3.2% CAGR from 2014 to 2020, the market is expected to rise to a valuation of US$13.3 bn.

How important will hospitals be to the mobile imaging services market in the coming years?

Despite their obvious utility in healthcare dispensation to remote areas or in home-based healthcare settings, the primary driver for the demand for mobile imaging services is their increasing use in hospitals. While stationary imaging equipment has been the norm in hospitals for a long time, the impending obsolescence of many imaging devices in the face of consistent technological advancement has necessitated the use of cost-effective modern alternatives such as mobile imaging.

Small hospitals are the key end users of mobile imaging services. These hospitals need to keep in touch with the contemporaneous technological scenario, but the relatively low volume of patients doesn’t allow them to install advanced stationary equipment on a mass scale. In this situation, using outsourced mobile imaging services becomes a vital solution for hospitals operating in a certain budget range. This is the way the mobile imaging services market has shaped up in North America and Europe. The increasing sophistication of teleradiology technologies is likely to ensure it remains this way in the coming years.

What is the key trend in the global mobile imaging services market?

The launch of mobile imaging units by major hospitals is a key trend in the global mobile imaging services market. While it has increased the demand for mobile imaging equipment, the high transportation costs and frequent maintenance requirements may put many hospitals off the idea of establishing their own mobile imaging unit. The increasing ease of incorporating teleradiology solutions is also likely to count against the mobile imaging services market, especially with smaller hospitals.

Read the Current Trends of Mobile Imaging Services Market at: http://www.transparencymarketresearch.com/mobile-imaging-services.html

The increasing global geriatric population has led to the development of imaging solutions that don’t require the patients to be physically present in the hospital, and home care solutions are already becoming common in North America and Western Europe, which are virtually the only markets for mobile imaging services at present. This is another key driver for the global mobile imaging services market.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Thriving Awareness among General Population Might Boost Mouth Ulcers Treatment Sales

While a large number of people suffer from mouth ulcers, many are reluctant to get a treatment and simply neglect the issue. It has been observed that the awareness regarding mouth ulcers treatment is quite low among the general population. Thus, companies operating in the mouth ulcers treatment market are undertaking extensive promotional and branding activities in order to create awareness about the available treatment options for mouth ulcers. Companies such as 3M ESPE have enabled online sales by offering a ‘Buy It Now’ option on their website. Other companies such as Piramal Healthcare have made use of popular and known faces such as Indian actor Sharman Joshi. Such marketing and promotional strategies are expected to drive the market in the coming years.

Obtain the Future Market Forecast of Mouth Ulcers Treatment at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2747

According to a report, published by Transparency Market Research, the global mouth ulcers treatment market was valued around US$1,242.6 mn in 2013 and is expected to reach about US$1,596.9 mn by the end of 2020.

In this blog post, TMR answers three critical questions about the mouth ulcers treatment market: 

Q. What are the factors driving the global mouth ulcers treatment market?

The increasing affordability and improvement in mouth ulcers treatment are having a positive impact on the market. In addition to this, the growing geriatric population is another factor benefitting the global mouth ulcers treatment market. This is because, elderly people are more prone to infections as their immune systems are weaker, making them more likely to get mouth ulcers, driving the market. Moreover, efforts are being take to create a heightened awareness among people regarding mouth ulcers and their available treatment methods. This is also expected to boost the demand for mouth ulcers treatment options.

Q. Which region is anticipated to have the potential for growth in the market?

The untapped markets in developing nations of Asia Pacific will prove to be lucrative in the coming years. The low awareness among people in these countries is expected to provide ample opportunities for growth in the mouth ulcers treatment market. Moreover, the number of tobacco consumers is highest in Asia Pacific, which means that many people are susceptible to mouth ulcers. This is another important factor why the mouth ulcers treatment market will flourish in Asia Pacific in the coming years, making it the region which will witness growth at the highest CAGR.

Read the Present Market Trends of Mouth Ulcers Treatment at: http://www.transparencymarketresearch.com/mouth-ulcers-treatment-market.html

Q. Which factors will hamper the growth of the market?

The threat of substitutes is expected to be high in the global mouth ulcers treatment market as medicines are being replaced by home remedies. This is expected to be the biggest challenge in the industry. The side effects associated with the use of mouth ulcers treatment options are also a cause of concern and may impact the demand for mouth ulcers treatment medicines negatively.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/